Bill
Bill > A5259
NJ A5259
NJ A5259Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.
summary
Introduced
02/28/2023
02/28/2023
In Committee
02/28/2023
02/28/2023
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.
AI Summary
This bill requires the State Health Benefits Program (SHBP), School Employees' Health Benefits Program (SEHBP), Medicaid, and NJ FamilyCare to cover anti-obesity medications under certain conditions. Specifically, the coverage is required if the individual has a diagnosis of obesity or an obesity-related medical condition from a licensed healthcare provider, is prescribed the medication by a licensed healthcare provider, and the medication is dispensed by an approved pharmacy. The bill also defines "anti-obesity medication" as a prescription drug approved by the FDA for chronic weight management for individuals who are obese or overweight and have at least one weight-related medical condition.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
Introduced, Referred to Assembly Health Committee (on 02/28/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/A5259 |
| BillText | https://pub.njleg.gov/Bills/2022/A5500/5259_I1.HTM |
Loading...